2 min read

Clinical Trial Trends – OCT West Coast Conference Wrap-Up

See key themes from this industry event on the clinical trial landscape.
Read the latest in the world of clinical trials out of this industry event.

Last week, leaders and scientists from the biotech and pharmaceutical industry gathered in San Francisco at the Outsourcing in Clinical Trials – West Coast Conference to share ideas and discuss recent clinical trial trends. A prominent theme discussed throughout the conference centered on the implementation of best practices to optimize the sponsor/service-provider dynamic.

UBC’s Aaron Berger PMP, SSGB, Senior Director Safety, Epidemiology, Registries, and Risk Management, delivered a presentation focusing on four key areas that have the potential to yield significant value for sponsors in the way they approach their service-provider relationships:

• Shared benefits of project pipeline transparency and coordinated resource planning
• Effective performance measurement and outcomes-based contracting
• Accelerating efficient price discovery
• The vital role of mission alignment and relationship-building

UBC is a leading provider of clinical development, pharmacovigilance, and evidence-generation services for the biopharmaceutical industry. By centering on the patient and building fit-for-purpose technology, we are able to capture the best of these emerging trends in clinical trials. Our unique expertise and approach to strategic engagements with our customers set us apart as an ideal partner for the clinical development and evidence-generation lifecycle.

To learn more about our solutions, please contact us to initiate the discussion on unlocking the value of strategic partnering.

Other Recent Posts

Press
4 min read

UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025

UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix®, and a major contender in the Post-approval category. The recognition highlights UBC’s strength in delivering innovative, compliant, and patient-focused PV solutions across the drug development lifecycle.
Press
5 min read

UBC Announces Partnership with Osmind to Advance the Future of Mental Health Treatment and Research within REMS

First-of-its-kind partnership in mental health care reduces REMS implementation burden, improves the quality of REMS data, and optimizes safe medication use and health outcomes
Press
5 min read

UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation

This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.